Special Issue "Pathomechanism of Neurological and Neuropsychiatric Disorders, Neurodegeneration and Neuroprotection"
Deadline for manuscript submissions: 31 August 2021.
Interests: antidepressant-like; anti-anxiety-like and cognitive effects of neuropeptides; hormones; kynurenine metabolites and their analogues; psychiatry; neurology; depression; anxiety; dementia; cognition; antidepressant; neuropeptides; neurohormones; tryptophan
Special Issues and Collections in MDPI journals
Special Issue in Biomedicines: Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry 2.0
Special Issue in Biomedicines: Selected Papers in the 1st International Electronic Conference on Biomedicine (ECB 2021)
Interests: neurology; headache; multiple sclerosis; Parkinson's disease; kynurenines; neurotransmission
Neurodegeneration is a common underlying pathomechanism in a wide range of neurologic diseases and psychiatric disorders which develop through polygenic interaction, multifactorial causative factors, and heterogenous pathogenesis. The neurologic diseases which manifest the neurodegeneration include Alzheimer’s diseases, Parkinson’s diseases, multiple sclerosis, amyotrophic lateralsclerosis, Huntington’s disease etc. while psychiatric disorders include depressive disorder, substance abuse disorder, anxiety disorder, post-traumatic stress disorder, bipolar disorder, schizophrenia, somatic symptom disorder, and autism spectrum disorder. Endogenous neuroprotective mechanisms play a crucial role in prodromal and remitting stages, preventing the onset and the exacerbation of the illness. Exogenous neuroprotective agents are under extensive investigation in attempt to intervene the course of neurodegenerative process to complement the endogenous neuroprotective operations and/or to counteract the neurodegenerative progression.
The Special Issue highlights the latest advance in research on pathomechanism, neurodegeneration, and neuroprotection, exploring novel interventional strategies in neurologic diseases and neuropsychiatric disorders.
We cordially invite authors to contribute original research articles focusing on, but not limited to the following:
- Etiology, pathogenesis, and progression mechanism in neurodegeneration;
- Early diagnosis including biomarker, bio-imaging, biosensors;
- Prophylactic, disease-modifying, and therapeutic strategies, novel targets;
- Novel drug discovery and development, naturally driven biomedicines, natural bioactive molecules, vaccines;
- Nanobiotechnology, nanosimilars, nanobiosimilars;
- Preclinical in vitro models, animal models, alternative methods;
- Bench-to-bedside translation research;
- Bedside-to-bench translational research.
Comprehensive review and research articles are also welcome.
Dr. Masaru Tanaka
Prof. Dr. László Vécsei
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.